The stock surged as much as 2% earlier in the day, but then reversed course and turned negative, and is currently witnessing volatile moves.
For the quarter that concluded in September, GM Breweries reported a 12.3% rise in its net profit from the same quarter last year to ₹39.3 crore from ₹35 crore last year.
In the June to September quarter, the Mumbai-based company saw an 18.2% increase in its topline, to ₹214 crore. The company had reported revenue number of ₹181 crore during the same quarter last year.
Operating performance by GM Breweries was strong when compared to the same quarter last year.
The company’s Earnings Before Interest, Tax, Depreciation and Amortisation (EBITDA) rose by 12% on a year-on-year basis to ₹50.3 crore from ₹45 crore in the second quarter of the financial year; however, EBITDA margins declined by over 250 basis points during the quarter to 23.5% from 25% in the year-ago period.
GM Breweries, the maker of Santra, G.M. Doctor, and G.M. Limbu Punch, is a key player in India’s country liquor market.
In the last quarter of the previous fiscal year, or Q4 of FY26, the company witnessed an 11% drop in its net profit, when compared to the same quarter last year.
When we take a sequential look at the company’s performance, in the first quarter of FY27 (Q1FY27), GM Breweries had reported a 46% rise in its net profit from the same quarter last year to ₹38 crore. GM Breweries had reported a 23% jump in its topline for the quarter that ended in June, to ₹200 crore.
How Did GM Breweries React To Its Results?
Shares of GM Breweries are now trading 4.1% lower on Thursday after the results announcement at ₹944.1. The stock is down 22% so far this year. Before today’s session, the stock had corrected 25% from its 52-week high of ₹1,328.8 and has gained in five out of the last 10 trading sessions.